Expert Talk : Active Surveillance helps fight Prostate Cancer

Expert Talk : Active Surveillance helps fight Prostate Cancer

Gleason 6 #ProstateCancer 101 | #MarkScholzMD #AlexScholz #PCRIПодробнее

Gleason 6 #ProstateCancer 101 | #MarkScholzMD #AlexScholz #PCRI

Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRIПодробнее

Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI

2023 Recap: New Treatments and Approaches in #ProstateCancer | #MarkScholzMD #AlexScholx #PCRIПодробнее

2023 Recap: New Treatments and Approaches in #ProstateCancer | #MarkScholzMD #AlexScholx #PCRI

Self Advocate and Do Your Own Research | Howard Wolinsky’s #ProstateCancer Patient Story | PCRIПодробнее

Self Advocate and Do Your Own Research | Howard Wolinsky’s #ProstateCancer Patient Story | PCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @aspi2020Подробнее

14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @aspi2020

Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRIПодробнее

Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRI

Navigating Prostate Cancer: Active Surveillance and Advanced Imaging InsightsПодробнее

Navigating Prostate Cancer: Active Surveillance and Advanced Imaging Insights

Micro-Ultrasound: New Developments in Prostate Imaging | #MarkScholzMD #AlexScholz #PCRIПодробнее

Micro-Ultrasound: New Developments in Prostate Imaging | #MarkScholzMD #AlexScholz #PCRI

Men’s Health | Online Health TalkПодробнее

Men’s Health | Online Health Talk

Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13Подробнее

Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13

Low Gleason Score (6 or 7) + High PSA? | Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

Low Gleason Score (6 or 7) + High PSA? | Prostate Cancer | Mark Scholz, MD | PCRI

Matthew Cooperberg, MD, MPH on Biomarkers in Prostate Cancer Active SurveillanceПодробнее

Matthew Cooperberg, MD, MPH on Biomarkers in Prostate Cancer Active Surveillance

Active Surveillance in 2022 | Laurence Klotz, MD | PCRIПодробнее

Active Surveillance in 2022 | Laurence Klotz, MD | PCRI

MRI Gadolinium Contrast: Is It Worth The Risk? | Imaging Expert, Daniel Margolis, MD Explains | PCRIПодробнее

MRI Gadolinium Contrast: Is It Worth The Risk? | Imaging Expert, Daniel Margolis, MD Explains | PCRI

Decipher, SelectMDx, and 4K Score in Active Surveillance & Intermediate Prostate Cancer | PCRIПодробнее

Decipher, SelectMDx, and 4K Score in Active Surveillance & Intermediate Prostate Cancer | PCRI

Prostate Cancer Surgical Treatment Options (September 2022) | Online Health TalkПодробнее

Prostate Cancer Surgical Treatment Options (September 2022) | Online Health Talk

PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MDПодробнее

PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD

Gleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRIПодробнее

Gleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRI